On April 18, 2024, we have successfully passed the “Good Distribution Practice (GDP)” conformity assessment conducted by TFDA. GDP, which stands for Good Distribution Practice, emphasizes maintaining the appropriate storage temperature conditions for pharmaceuticals during transportation and storage. It ensures that the quality of pharmaceuticals is not compromised by changes in the storage environment and requires that all distribution processes to have clear and precise records.
This achievement marks our commitment to maintaining the highest quality in pharmaceutical storage and transportation operations.